Merge pull request #2113 from EBISPOT/2105

Added measurement terms for #2105

src/ontology/efo-edit.owl

@@ -16667,7 +16667,12 @@ Declaration(Class(efo:EFO_0022373))
 Declaration(Class(efo:EFO_0022374))
 Declaration(Class(efo:EFO_0022375))
 Declaration(Class(efo:EFO_0022376))
+Declaration(Class(efo:EFO_0022377))
+Declaration(Class(efo:EFO_0022378))
+Declaration(Class(efo:EFO_0022379))
 Declaration(Class(efo:EFO_0022380))
+Declaration(Class(efo:EFO_0022381))
+Declaration(Class(efo:EFO_0022382))
 Declaration(Class(efo:EFO_0022386))
 Declaration(Class(efo:EFO_0022388))
 Declaration(Class(efo:EFO_0022389))
@@ -200848,6 +200853,37 @@ AnnotationAssertion(rdfs:label efo:EFO_0022376 "b5-589 cell")
 SubClassOf(efo:EFO_0022376 obo:CL_0000010)
 SubClassOf(efo:EFO_0022376 ObjectSomeValuesFrom(obo:RO_0001000 ObjectIntersectionOf(obo:CL_0002327 ObjectSomeValuesFrom(obo:BFO_0000050 ObjectIntersectionOf(efo:EFO_0000635 ObjectSomeValuesFrom(obo:BFO_0000050 obo:OBI_0100026))))))
 
+# Class: efo:EFO_0022377 (ankylosing spondylitis disease activity score)
+
+AnnotationAssertion(Annotation(efo:definition_citation "PMID:37659414") obo:IAO_0000115 efo:EFO_0022377 "The Ankylosing Spondylitis Disease Activity Score (ASDAS) is an index to assess disease activity in Ankylosing Spondylitis (AS).")
+AnnotationAssertion(obo:IAO_0000117 efo:EFO_0022377 "Santhi Ramachandran")
+AnnotationAssertion(dc:creator efo:EFO_0022377 "Zoe May Pendlington")
+AnnotationAssertion(dc:date efo:EFO_0022377 "2023-10-13T08:28:55Z"^^xsd:dateTime)
+AnnotationAssertion(oboInOwl:hasExactSynonym efo:EFO_0022377 "ASDAS")
+AnnotationAssertion(rdfs:label efo:EFO_0022377 "ankylosing spondylitis disease activity score"@en)
+SubClassOf(efo:EFO_0022377 efo:EFO_0001444)
+SubClassOf(efo:EFO_0022377 ObjectSomeValuesFrom(obo:IAO_0000136 efo:EFO_0003898))
+
+# Class: efo:EFO_0022378 (response to secukinumab)
+
+AnnotationAssertion(Annotation(efo:definition_citation "PMID:37659414") obo:IAO_0000115 efo:EFO_0022378 "Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a secukinumab stimulus.")
+AnnotationAssertion(obo:IAO_0000117 efo:EFO_0022378 "Santhi Ramachandran")
+AnnotationAssertion(dc:creator efo:EFO_0022378 "Zoe May Pendlington")
+AnnotationAssertion(dc:date efo:EFO_0022378 "2023-10-13T08:31:56Z"^^xsd:dateTime)
+AnnotationAssertion(rdfs:label efo:EFO_0022378 "response to secukinumab"@en)
+SubClassOf(efo:EFO_0022378 efo:EFO_0010051)
+
+# Class: efo:EFO_0022379 (American College of Rheumatology Improvement Criteria)
+
+AnnotationAssertion(Annotation(efo:definition_citation "PMID:37659414") obo:IAO_0000115 efo:EFO_0022379 "Standard criteria to compare the effectiveness of medications or treatments for rheumatoid diseases. The American College of Rheumatology criteria consists of a variety of physical assessments, laboratory evaluation, and patient assessments (NCIT).")
+AnnotationAssertion(obo:IAO_0000117 efo:EFO_0022379 "Santhi Ramachandran")
+AnnotationAssertion(dc:creator efo:EFO_0022379 "Zoe May Pendlington")
+AnnotationAssertion(dc:date efo:EFO_0022379 "2023-10-13T08:33:41Z"^^xsd:dateTime)
+AnnotationAssertion(oboInOwl:hasDbXref efo:EFO_0022379 "NCIT:C97995")
+AnnotationAssertion(oboInOwl:hasExactSynonym efo:EFO_0022379 "ACR Improvement Criteria")
+AnnotationAssertion(rdfs:label efo:EFO_0022379 "American College of Rheumatology Improvement Criteria"@en)
+SubClassOf(efo:EFO_0022379 efo:EFO_0001444)
+
 # Class: efo:EFO_0022380 (L-428 cell)
 
 AnnotationAssertion(obo:IAO_0000115 efo:EFO_0022380 "Human Hodgkin lymphoma L-428 cells")
@@ -200859,6 +200895,28 @@ SubClassOf(efo:EFO_0022380 obo:CL_0000010)
 SubClassOf(efo:EFO_0022380 ObjectSomeValuesFrom(obo:RO_0000053 efo:EFO_0000183))
 SubClassOf(efo:EFO_0022380 ObjectSomeValuesFrom(obo:RO_0001000 ObjectIntersectionOf(efo:EFO_0000324 ObjectSomeValuesFrom(obo:BFO_0000050 ObjectIntersectionOf(obo:UBERON_0000977 ObjectSomeValuesFrom(obo:BFO_0000050 obo:NCBITaxon_9606))))))
 
+# Class: efo:EFO_0022381 (Health Assessment Questionnaire Disability Index)
+
+AnnotationAssertion(Annotation(efo:definition_citation "PMID:37659414") obo:IAO_0000115 efo:EFO_0022381 "A questionnaire for the assessment of arthritis")
+AnnotationAssertion(obo:IAO_0000117 efo:EFO_0022381 "Santhi Ramachandran")
+AnnotationAssertion(dc:creator efo:EFO_0022381 "Zoe May Pendlington")
+AnnotationAssertion(dc:date efo:EFO_0022381 "2023-10-13T08:35:26Z"^^xsd:dateTime)
+AnnotationAssertion(oboInOwl:hasDbXref efo:EFO_0022381 "NCIT:C132288")
+AnnotationAssertion(oboInOwl:hasExactSynonym efo:EFO_0022381 "HAQ-DI")
+AnnotationAssertion(rdfs:label efo:EFO_0022381 "Health Assessment Questionnaire Disability Index"@en)
+SubClassOf(efo:EFO_0022381 efo:EFO_0001444)
+
+# Class: efo:EFO_0022382 (psoriasis area and severity index)
+
+AnnotationAssertion(Annotation(efo:definition_citation "PMID:37659414") obo:IAO_0000115 efo:EFO_0022382 "A standardized survey developed by Fredriksson and Pettersson in 1978 to calculate the intensity and extent of psoriatic plaques before, during, and after retinoid treatment in chronic plaquetype psoriasis. The instrument utilizes a 5-point rating scale to measure intensity and assigns a numerical score for the percentage of anatomical involvement.")
+AnnotationAssertion(obo:IAO_0000117 efo:EFO_0022382 "Santhi Ramachandran")
+AnnotationAssertion(dc:creator efo:EFO_0022382 "Zoe May Pendlington")
+AnnotationAssertion(dc:date efo:EFO_0022382 "2023-10-13T08:37:22Z"^^xsd:dateTime)
+AnnotationAssertion(oboInOwl:hasDbXref efo:EFO_0022382 "NCIT:C135734")
+AnnotationAssertion(oboInOwl:hasExactSynonym efo:EFO_0022382 "PASI")
+AnnotationAssertion(rdfs:label efo:EFO_0022382 "psoriasis area and severity index"@en)
+SubClassOf(efo:EFO_0022382 efo:EFO_0001444)
+
 # Class: efo:EFO_0022386 (HEP-3B cell)
 
 AnnotationAssertion(obo:IAO_0000115 efo:EFO_0022386 "human hepatocellular carcinoma (HCC) cells (p53-null).")